A virus-induced circular RNA maintains latent infection of Kaposi’s sarcoma herpesvirus
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2212864120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Takanobu Tagawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: HIV and AIDS Malignancy Branch, Center of Cancer Research, National Cancer Institute, Bethesda, MD 20892. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Sarcoma, Kaposi, Epstein-Barr Virus Infections, Latent Infection. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, HHS | NIH | National Cancer Institute.
Abstract (Originalsprache)
Non-coding RNAs (ncRNAs) play important roles in host-pathogen interactions; oncogenic viruses like Kaposi’s sarcoma herpesvirus (KSHV) employ ncRNAs to establish a latent reservoir and persist for the life of the host. We previously reported that KSHV infection alters a novel class of RNA, circular RNAs (circRNAs). CircRNAs are alternative splicing isoforms and regulate gene expression, but their importance in infection is largely unknown. Here, we showed that a human circRNA, hsa_circ_0001400, is induced by various pathogenic viruses, namely KSHV, Epstein-Barr virus, and human cytomegalovirus. The induction of circRNAs including circ_0001400 by KSHV is co-transcriptionally regulated, likely at splicing. Consistently, screening for circ_0001400-interacting proteins identified a splicing factor, PNISR. Functional studies using infected primary endothelial cells revealed that circ_0001400 inhibits KSHV lytic transcription and virus production. Simultaneously, the circRNA promoted cell cycle, inhibited apoptosis, and induced immune genes. RNA-pull down assays identified transcripts interacting with circ_0001400, including TTI1 , which is a component of the pro-growth mTOR complexes. We thus identified a circRNA that is pro-growth and anti-lytic replication. These results support a model in which KSHV induces circ_0001400 expression to maintain latency. Since circ_0001400 is induced by multiple viruses, this novel viral strategy may be widely employed by other viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV and AIDS Malignancy Branch, Center of Cancer Research, National Cancer Institute, Bethesda, MD 20892.
- Center for Cancer Research Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892.
- Advanced Biomedical Computational Sciences, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701.
- Protein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701.
ORCID-Profile: Takanobu Tagawa, Daniel Oh, Sarah Dremel, Guruswamy Mahesh, Vishal N Koparde, Thorkell Andresson, Joseph M Ziegelbauer
Förderung
- Intramural NIH HHS
- HHS | NIH | National Cancer Institute
Zitieren
APA
Tagawa, T., Oh, D., Dremel, S., Mahesh, G., Koparde, V. N., Duncan, G., Andresson, T., & Ziegelbauer, J. M. (2023). A virus-induced circular RNA maintains latent infection of Kaposi’s sarcoma herpesvirus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2212864120
Vancouver
Tagawa T, Oh D, Dremel S, Mahesh G, Koparde VN, Duncan G, et al. A virus-induced circular RNA maintains latent infection of Kaposi’s sarcoma herpesvirus. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2212864120
BibTeX
@article{Tagawa2023,
author = {Tagawa, Takanobu and Oh, Daniel and Dremel, Sarah and Mahesh, Guruswamy and Koparde, Vishal N and Duncan, Gerard and Andresson, Thorkell and Ziegelbauer, Joseph M},
title = {A virus-induced circular RNA maintains latent infection of Kaposi’s sarcoma herpesvirus},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2212864120}
}
EUVIMED